Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction

Circulation
Frank AndersohnEdeltraut Garbe

Abstract

The cardiovascular safety of cyclooxygenase (COX)-2-selective nonsteroidal antiinflammatory drugs (NSAIDs) has come under scrutiny after the withdrawal of rofecoxib and halting of the Adenoma Prevention with Celecoxib trial. Whether the newer second-generation COX-2 inhibitors (etoricoxib, valdecoxib) also increase the cardiovascular risk is unknown. We performed a nested case-control study in a cohort of 486,378 persons registered within the United Kingdom General Practice Research Database with at least 1 prescription of an NSAID between June 1, 2000, and October 31, 2004. A total of 3643 cases with acute myocardial infarction (AMI) were matched to 13,918 controls on age, sex, year of cohort entry, and general practice. Rate ratios (RRs) of AMI associated with use of COX-2-selective and -nonselective NSAIDs were calculated. Current use of etoricoxib was associated with a 2.09-fold (95% confidence interval [CI], 1.10 to 3.97) risk of AMI compared with no use of NSAIDs during the prior year. Current use of rofecoxib (RR=1.29; 95% CI, 1.02 to 1.63), celecoxib (RR=1.56; 95% CI, 1.22 to 2.00), and diclofenac (RR=1.37; 95% CI, 1.17 to 1.59) also significantly increased the AMI risk. For current use of valdecoxib, the RR was 4.60 (9...Continue Reading

References

Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B F McAdamG A FitzGerald
Apr 23, 1999·Lancet·T Walley, A Mantgani
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Aug 11, 2001·The New England Journal of Medicine·G A FitzGerald, C Patrono
May 22, 2002·Archives of Internal Medicine·Douglas J WatsonHarry A Guess
May 22, 2002·Archives of Internal Medicine·Elham RahmeJacques LeLorier
Sep 19, 2002·British Journal of Clinical Pharmacology·Raymond G SchliengerChristoph R Meier
May 14, 2003·Pharmacotherapy·Susan S JickHershel Jick
Dec 12, 2003·Nature Reviews. Drug Discovery·Garret A FitzGerald
Jun 16, 2004·Circulation·Luis A García RodríguezAntonio González-Pérez
Oct 8, 2004·The New England Journal of Medicine·Garret A Fitzgerald
Dec 8, 2004·Lancet·Peter JüniMatthias Egger
Feb 3, 2005·Annals of Internal Medicine·Stephen E KimmelBrian L Strom
Feb 17, 2005·The New England Journal of Medicine·Robert S BresalierUNKNOWN Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators
Feb 17, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Adenoma Prevention with Celecoxib (APC) Study Investigators
Feb 17, 2005·The New England Journal of Medicine·Nancy A NussmeierKenneth M Verburg
Mar 10, 2005·The Annals of Pharmacotherapy·Nigel S B RawsonDavid J Graham
Jun 16, 2005·The Annals of Pharmacotherapy·S Christopher Jones

❮ Previous
Next ❯

Citations

May 26, 2009·European Journal of Drug Metabolism and Pharmacokinetics·V JakovljevicA Rasković
Nov 6, 2008·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·F HoffmannE Garbe
Nov 6, 2008·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·F Andersohn, E Garbe
Dec 6, 2006·European Journal of Clinical Pharmacology·Arja Helin-Salmivaara, Jaana E Martikainen
Nov 14, 2007·European Journal of Clinical Pharmacology·Shaojun Shi, Ulrich Klotz
Jan 5, 2008·Current Pain and Headache Reports·Gayle McKellarGurkirpal Singh
Sep 23, 2006·Nature Clinical Practice. Cardiovascular Medicine·Scott D Solomon
Nov 27, 2007·Nature Clinical Practice. Rheumatology·Samy Suissa, Edeltraut Garbe
Dec 1, 2006·The New England Journal of Medicine·Frank AndersohnEdeltraut Garbe
Jul 27, 2007·The New England Journal of Medicine·David J KerrUNKNOWN VICTOR Trial Group
Oct 12, 2010·Teaching and Learning in Medicine·Bruce J NaughtonDiana R Anderson
Aug 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Paolo FabbriniJaap van den Born
May 23, 2008·American Journal of Therapeutics·Warren A Katz, Robert L Barkin
May 23, 2008·American Journal of Therapeutics·Allan Gibofsky, Robert L Barkin
Apr 1, 2008·International Journal of Clinical Practice·C J SmithM Fisher
Dec 20, 2007·BMC Cardiovascular Disorders·Joseph A C DelaneySamy Suissa
Jul 6, 2007·BMC Gastroenterology·Michael LoydPhilip Jacobs
Dec 7, 2013·Arthritis Research & Therapy·Anne Tuskey, David Peura
Oct 25, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Atsushi HirayamaUNKNOWN all ACCEPT study investigators in Japan
Dec 4, 2009·Therapeutics and Clinical Risk Management·Gayle McKellar, Gurkirpal Singh
Feb 6, 2009·Drugs·Marco Lazzaroni, Gabriele Bianchi Porro
Jan 6, 2011·Surgical Neurology International·Joseph C MaroonAdara Maroon
May 26, 2012·Canadian Journal of Physiology and Pharmacology·Chris R TriggleHong Ding
Aug 29, 2007·The Journal of Experimental Medicine·Mallika GhoshTimothy Hla
Oct 1, 2013·Current Opinion in Cardiology·Anne-Marie Schjerning OlsenEmil L Fosbøl
Oct 21, 2006·Current Opinion in Cardiology·Scott D Solomon
Oct 2, 2007·Current Opinion in Gastroenterology·James M Brophy
Jul 1, 2009·Expert Opinion on Therapeutic Patents·Teodorico C RamalhoMatheus P Freitas
Oct 3, 2009·Expert Opinion on Pharmacotherapy·Craig T Hartrick
Nov 13, 2013·Expert Opinion on Drug Metabolism & Toxicology·Bhulan Kumar SinghKrishna Kolappa Pillai
Nov 22, 2013·Expert Opinion on Drug Safety·Nicholas MooreAntoine Pariente
Jun 24, 2010·Expert Opinion on Drug Safety·Emil Loldrup FosbølGunnar H Gislason
Oct 29, 2008·Current Medical Research and Opinion·Daniel Brzusek, David Petron

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.